| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239128 Combating diseases and disorders associated with or mediated by the release of excitatory amino acids, associated with reduced blood flow to the brain and other cns tissue, |
| 05/29/2001 | US6238931 Particles with energy donors and acceptors as well as proteins, polypeptides, nucleic acids, or ligand analogues bound to surface; with reduced quenching and improved fluorescence intensities; immunoassays |
| 05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
| 05/29/2001 | CA2053339C Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | WO2001036421A1 Novel [1,2,3]-triazolo[4,5-d]pyrimidine compounds |
| 05/25/2001 | WO2001036420A1 Tricyclic azaindolizine derivatives having an spla2- inhibiting effect |
| 05/25/2001 | WO2001036417A1 New use and novel n-azabicyclo-amide derivatives |
| 05/25/2001 | WO2001036416A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | WO2001036388A1 Aza compounds having neuronal activity |
| 05/25/2001 | WO2000077027A3 Serine protease inhibitors |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2001 | CA2391913A1 Novel thiazolidinedione derivatives as antidiabetic agents |
| 05/25/2001 | CA2391291A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | CA2390071A1 Aza compounds having neuronal activity |
| 05/25/2001 | CA2389604A1 New use and novel n-azabicyclo-amide derivatives |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100770A2 Monomers and network polymers obtained therefrom |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100505A1 A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 05/23/2001 | CN1066150C Bridged indole as matrix metalloprotease inhibitors |
| 05/23/2001 | CN1066149C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 05/23/2001 | CN1066148C Tricyclic benzazepine compounds |
| 05/22/2001 | US6235767 Methods to treat arterial plaque |
| 05/22/2001 | US6235764 Isothiazole derivatives useful as anticancer agents |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones |
| 05/22/2001 | US6235741 Angiogenesis inhibitors |
| 05/22/2001 | US6235740 Autoimmune diseases; antiproliferation agents |
| 05/22/2001 | US6234811 Stereoselective synthesis |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | WO2001034578A1 Compounds with anti-helicobacter pylori activity |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001034152A1 Nasal drops containing fused pyridazine derivatives |
| 05/17/2001 | WO2001002404A3 Method for producing triethylene diamine, using ethylene diamine |
| 05/17/2001 | WO2000078881A3 Process for the preparation of herbicidal derivatives |
| 05/17/2001 | CA2390919A1 Nose drop containing condensed pyridazine |
| 05/17/2001 | CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | CA2387624A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | CA2361139A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods |
| 05/16/2001 | EP1099744A2 Organic electroluminescent device |
| 05/16/2001 | EP1099702A1 Substituted morpholine derivatives and their use as therapeutic agents |
| 05/16/2001 | EP1098896A1 5-bicycloindole compounds |
| 05/16/2001 | EP1098883A1 Process for preparing heterocyclic compounds |
| 05/16/2001 | CN1295574A Porphyrins and their use as photosensitizer |
| 05/16/2001 | CN1295570A N-pyriconyl herbicides |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof |
| 05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/15/2001 | USRE37180 Photochemotherapeutical obstruction of newly-formed blood vessels |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232281 Phthalocyanine, naphthalocyanine, anthralocyanine, and phenanthralocyanine complexes; bleaches for laundry detergents |
| 05/10/2001 | WO2001032660A1 Compounds having 5-ht6 receptor antagonist activity |
| 05/10/2001 | WO2001032659A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders |
| 05/10/2001 | WO2001032646A2 Sulfonamide derivatives |
| 05/10/2001 | WO2001032632A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 05/10/2001 | WO2001032615A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | WO2001032577A1 Pigmented vitreous material its precursor glass items coated therewith and method of its preparation |
| 05/10/2001 | WO2001032264A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 05/10/2001 | WO2001017973A3 Novel herbicides |
| 05/10/2001 | CA2389645A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 05/10/2001 | CA2389226A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/09/2001 | EP1097935A1 Novel x-ray intercepting metal complexes of chlorin derivatives |
| 05/09/2001 | EP1097920A1 Intermediate for condensed benzazepine derivatives |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097711A2 Treatment of pulmonary hypertension |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097153A1 Novel triazolo[4,5-d]pyrimidine compounds |
| 05/09/2001 | EP1097152A2 Synthesis of compounds useful in the manufacture of ketorolac |
| 05/09/2001 | CN1294593A Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1065535C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 05/08/2001 | US6229013 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228869 Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228853 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/08/2001 | US6228847 Inhibitors of nucleoside metabolism |
| 05/08/2001 | US6228553 Pyrrolo [1,2-A] pyrimidine compound and heat-sensitive recording material using the same |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/03/2001 | WO2001030967A2 Fluorescent cobalamins and uses thereof |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 05/03/2001 | WO2001002370B1 Nickel-based reagents for detecting dna and dna-protein contacts |
| 05/03/2001 | CA2388611A1 Transdermal drug delivery devices |